Search

everythinglearnresearchcommunity

for

Search:↓

Men with early balding may have hormonal imbalances similar to women with PCOS and could benefit from similar treatments.

Exercise is crucial for managing polycystic ovary syndrome (PCOS) and improving overall health.

Leuprolide may better manage cholesterol and blood pressure in PCOS than spironolactone.

Glypican-4 may help indicate insulin sensitivity and lipid issues in women with PCOS.

Melanoma patients can learn to check their skin, early balding in men may indicate similar risks as PCOS in women, certain criteria can help predict skin cancer behavior, small skin cancer may not need extra therapy after surgery, and sterile gloves don't reduce infection in minor surgeries.

Combining liraglutide and metformin helps obese women with PCOS who didn't lose weight on metformin alone to lose more weight.

Finasteride is effective and safe for treating hidradenitis suppurativa in both adults and some younger patients.

There may be a link between hair loss and heart disease in women, but more research is needed.

Multi-omics techniques help understand the molecular causes of androgenetic alopecia.

The conclusion is that removing both ovaries is the best treatment for excess male hormones in postmenopausal women, with medication as another option, and managing insulin resistance is important for diagnosis and treatment.

Newer low-dose oral contraceptives with less androgenic effects improve patient compliance.

Insulin resistance is linked to high male hormone levels in women, often seen in those with PCOS.

Menstrual abnormalities in PCOS women may not greatly affect their metabolic and hormonal profile.

High-intensity interval training improves certain hormone levels and lipid profiles in women with PCOS.

Understanding metabolic changes in dormant cells can help treat cancer.

Myo-inositol improves fertility and metabolic health in PCOS with fewer side effects than metformin.

Women with PCOS have different body composition and some metabolic differences compared to healthy women.

The type of PCOS a woman has doesn't strongly predict her skin or metabolic symptoms; obesity is a more important factor.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Hair follicle stem cells may cause squamous cell carcinoma due to a metabolic shift towards glycolysis.

Ulcerative colitis involves immune activation, chronic inflammation, and metabolic issues, some of which persist even during remission.

Ethnicity affects how polycystic ovary syndrome shows up in women, with white women having higher metabolic risks but less diabetes, and South Asian women showing more androgenic symptoms and being younger at presentation.

Lower LDL-c levels predict higher COVID-19 mortality.

Dienogest combined with ethinylestradiol is a highly effective birth control that improves menstrual symptoms and has manageable side effects.

Metformin works better for adolescent girls with PCOS who have certain genetic variations.

Inositol improves metabolism, hormone balance, and reproductive health in women with PCOS and obesity.

Finasteride 1 mg reduces semen quality without affecting hormones.

Finasteride 1 mg/day reduces semen quality without affecting hormones or sexual function.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

Taking DHEA for a year is generally safe for postmenopausal women but may cause acne and more facial hair without improving metabolism or aging.